Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors

[1]  E. Carosella,et al.  Tolerogenic Function of Dimeric Forms of HLA-G Recombinant Proteins: A Comparative Study In Vivo , 2011, PloS one.

[2]  S. Agaugué,et al.  Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17. , 2011, Blood.

[3]  Des C. Jones,et al.  HLA Class I Allelic Sequence and Conformation Regulate Leukocyte Ig-Like Receptor Binding , 2011, The Journal of Immunology.

[4]  E. Carosella,et al.  HLA-G Expression in Human Embryonic Stem Cells and Preimplantation Embryos , 2011, The Journal of Immunology.

[5]  E. Hauben,et al.  Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. , 2010, Blood.

[6]  J. Dausset,et al.  Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6—STAT3 signaling pathway , 2008, Proceedings of the National Academy of Sciences.

[7]  N. Rouas-Freiss,et al.  Beyond the increasing complexity of the immunomodulatory HLA-G molecule. , 2008, Blood.

[8]  F. Gros,et al.  Soluble HLA‐G molecules impair natural killer/dendritic cell crosstalk via inhibition of dendritic cells , 2008, European journal of immunology.

[9]  N. Rouas-Freiss,et al.  Human Leukocyte Antigen‐G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T Cells , 2008, Stem cells.

[10]  J. S. Hunt,et al.  Synthesis of β2‐microglobulin‐free, disulphide‐linked HLA‐G5 homodimers in human placental villous cytotrophoblast cells , 2007, Immunology.

[11]  P. Moreau,et al.  Trogocytosis‐based generation of suppressive NK cells , 2007, The EMBO journal.

[12]  E. Carosella,et al.  Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. , 2006, Blood.

[13]  Kouhei Tsumoto,et al.  Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d) , 2006, Proceedings of the National Academy of Sciences.

[14]  Kouhei Tsumoto,et al.  Efficient Leukocyte Ig-like Receptor Signaling and Crystal Structure of Disulfide-linked HLA-G Dimer* , 2006, Journal of Biological Chemistry.

[15]  A. Blaschitz,et al.  A novel sandwich ELISA for alpha1 domain based detection of soluble HLA-G heavy chains. , 2005, Journal of immunological methods.

[16]  N. Rouas-Freiss,et al.  Modulation of HLA-G Expression in Human Neural Cells after Neurotropic Viral Infections , 2005, Journal of Virology.

[17]  M. Weller,et al.  Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. , 2005, Brain : a journal of neurology.

[18]  Wei Zhang,et al.  Tolerization of dendritic cells by HLA‐G , 2005, European journal of immunology.

[19]  J. McCluskey,et al.  Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[20]  N. Rouas-Freiss,et al.  Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis. , 2004, Blood.

[21]  N. Rouas-Freiss,et al.  SOLUBLE HLA-G INHIBITS CELL CYCLE PROGRESSION IN HUMAN ALLOREACTIVE T LYMPHOCYTES , 2004 .

[22]  J. Dausset,et al.  HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. S. Hunt,et al.  Placental Cell Expression of HLA-G2 Isoforms Is Limited to the Invasive Trophoblast Phenotype 1 , 2003, The Journal of Immunology.

[24]  J. Hanna,et al.  Complexes of HLA-G Protein on the Cell Surface Are Important for Leukocyte Ig-Like Receptor-1 Function1 , 2003, The Journal of Immunology.

[25]  T. Elliott,et al.  Lymphoblastoid cells express HLA‐B27 homodimers both intracellularly and at the cell surface following endosomal recycling , 2003, European journal of immunology.

[26]  J. Strominger,et al.  Disulfide bond-mediated dimerization of HLA-G on the cell surface , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[27]  B. Baibakov,et al.  HLA‐G inhibits the functions of murine dendritic cells via the PIR‐B immune inhibitory receptor , 2002, European journal of immunology.

[28]  J. Dausset,et al.  Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule , 2002, AIDS.

[29]  L. Dubertret,et al.  HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells? , 2001, The American journal of pathology.

[30]  J. Dausset,et al.  Characterization of HLA-G1, -G2, -G3, and -G4 isoforms transfected in a human melanoma cell line. , 2001, Transplantation proceedings.

[31]  J. Dausset,et al.  HLA-G2, -G3, and -G4 Isoforms Expressed as Nonmature Cell Surface Glycoproteins Inhibit NK and Antigen-Specific CTL Cytolysis1 , 2001, The Journal of Immunology.

[32]  G. Ferrara,et al.  HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression. , 2000, Human immunology.

[33]  I. Sargent,et al.  HLA-G suppresses proliferation of CD4(+) T-lymphocytes. , 2000, Journal of reproductive immunology.

[34]  J. Dausset,et al.  Implication of HLA-G molecule in heart-graft acceptance , 2000, The Lancet.

[35]  J. Dausset,et al.  Polymorphism of HLA-G gene and protein. , 1999, Journal of reproductive immunology.

[36]  J. Dausset,et al.  HLA-G inhibits the allogeneic proliferative response. , 1999, Journal of reproductive immunology.

[37]  S. Fournel,et al.  HLA-G in the human thymus: a subpopulation of medullary epithelial but not CD83(+) dendritic cells expresses HLA-G as a membrane-bound and soluble protein. , 1999, International immunology.

[38]  Eric O Long,et al.  A Human Histocompatibility Leukocyte Antigen (HLA)-G–specific Receptor Expressed on All Natural Killer Cells , 1999, The Journal of experimental medicine.

[39]  J. Dausset,et al.  HLA-G: a tolerance molecule from the major histocompatibility complex. , 1999, Immunology today.

[40]  J. Dausset,et al.  HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[41]  G. Ogg,et al.  Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. , 1998, Journal of immunology.

[42]  M. Colonna,et al.  A Common Inhibitory Receptor for Major Histocompatibility Complex Class I Molecules on Human Lymphoid and Myelomonocytic Cells , 1997, The Journal of experimental medicine.

[43]  J. Dausset,et al.  Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Dausset,et al.  HLA-G gene polymorphism segregation within CEPH reference families. , 1997, Human immunology.

[45]  J. Ritz,et al.  Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. , 1996, Experimental hematology.

[46]  S. Fisher,et al.  A class I antigen, HLA-G, expressed in human trophoblasts. , 1990, Science.

[47]  A. McMichael,et al.  Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line. , 1986, Immunology.